175 related articles for article (PubMed ID: 32627692)
21. Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometry.
Guo L; Wang Z; Anderson CM; Doolittle E; Kernag S; Cotta CV; Ondrejka SL; Ma XJ; Cook JR
Mod Pathol; 2018 Mar; 31(3):385-394. PubMed ID: 29052600
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical characterization of lambda light-chain-derived amyloid in one feline and five canine plasma cell tumors.
Rowland PH; Linke RP
Vet Pathol; 1994 May; 31(3):390-3. PubMed ID: 8053139
[No Abstract] [Full Text] [Related]
23. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
Ramos-Vara JA; Miller MA; Valli VE
Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
[TBL] [Abstract][Full Text] [Related]
24. Detection of kappa- and lambda-expressing cells in the endometrium by in situ hybridization.
Euscher E; Nuovo GJ
Int J Gynecol Pathol; 2002 Oct; 21(4):383-90. PubMed ID: 12352187
[TBL] [Abstract][Full Text] [Related]
25. Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.
Shao H; Xi L; Raffeld M; Pittaluga S; Dunleavy K; Wilson WH; Spector N; Milito C; Morais JC; Jaffe ES
Am J Surg Pathol; 2010 Oct; 34(10):1425-35. PubMed ID: 20871216
[TBL] [Abstract][Full Text] [Related]
26. Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status.
Madrid MA; Lo RW
Breast Cancer Res; 2004; 6(5):R593-600. PubMed ID: 15318940
[TBL] [Abstract][Full Text] [Related]
27. Untranslated immunoglobulin kappa light chain mRNA in a lambda light chain-producing mouse myeloma, MOPC104E.
Kataoka T; Ono M; Kawakami M; Ikawa Y; Aida M; Mano Y; Honjo T
J Biol Chem; 1980 Jun; 255(11):5291-5. PubMed ID: 6768738
[TBL] [Abstract][Full Text] [Related]
28. [Comparision of HER2/neu oncogene detected by chromogenic in-situ hybridization and immunohistochemistry in breast cancer].
Zhang GH; Shi DR; Liang XM; Hou JH; Kang SY; Zhu WD; Li XB; Shao Y; Chen LR; Zhou Y
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):580-3. PubMed ID: 17134562
[TBL] [Abstract][Full Text] [Related]
29. Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders.
Tubbs RR; Wang H; Wang Z; Minca EC; Portier BP; Gruver AM; Lanigan C; Luo Y; Cook JR; Ma XJ
Am J Clin Pathol; 2013 Nov; 140(5):736-46. PubMed ID: 24124155
[TBL] [Abstract][Full Text] [Related]
30. Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH).
Fischer I; de la Cruz C; Rivera AL; Aldape K
Diagn Mol Pathol; 2008 Dec; 17(4):227-30. PubMed ID: 18382350
[TBL] [Abstract][Full Text] [Related]
31. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
[TBL] [Abstract][Full Text] [Related]
32. [HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].
Akhdar A; Bronsard M; Lemieux R; Geha S
Ann Pathol; 2011 Dec; 31(6):472-9. PubMed ID: 22172120
[TBL] [Abstract][Full Text] [Related]
33. Myeloma associated with immunoglobulin lambda-light chain derived amyloid in a dog.
Geisel O; Stiglmair-Herb M; Linke RP
Vet Pathol; 1990 Sep; 27(5):374-6. PubMed ID: 2122573
[No Abstract] [Full Text] [Related]
34. Intestinal multinodular A lambda-amyloid deposition associated with extramedullary plasmacytoma in three dogs: clinicopathological and immunohistochemical studies.
Ramos-Vara JA; Miller MA; Pace LW; Linke RP; Common RS; Watson GL
J Comp Pathol; 1998 Oct; 119(3):239-49. PubMed ID: 9807726
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical examination of light-chain expression (lambda/kappa ratio) in canine, feline, equine, bovine and porcine plasma cells.
Arun SS; Breuer W; Hermanns W
Zentralbl Veterinarmed A; 1996 Nov; 43(9):573-6. PubMed ID: 8968166
[TBL] [Abstract][Full Text] [Related]
36. Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma.
Zhao J; Wu R; Au A; Marquez A; Yu Y; Shi Z
Mod Pathol; 2002 Jun; 15(6):657-65. PubMed ID: 12065780
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of HER2 gene amplification and its protein expression in 165 cases of breast carcinoma: comparison of chromogenic in-situ hybridization and immunohistochemistry].
Shen DH; Wang FH; Yu YZ
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):457-60. PubMed ID: 17845758
[TBL] [Abstract][Full Text] [Related]
38. Ig lambda-producing B cells do not show feedback inhibition of gene rearrangement.
Gollahon KA; Hagman J; Brinster RL; Storb U
J Immunol; 1988 Oct; 141(8):2771-80. PubMed ID: 3139764
[TBL] [Abstract][Full Text] [Related]
39. A divergent pseudoglandular configuration of cutaneous plasmacytoma in dogs.
McHale B; Blas-Machado U; Oliveira FN; Rissi DR
J Vet Diagn Invest; 2018 Mar; 30(2):260-262. PubMed ID: 29153038
[TBL] [Abstract][Full Text] [Related]
40. A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum.
Lavatelli F; Brambilla F; Valentini V; Rognoni P; Casarini S; Di Silvestre D; Perfetti V; Palladini G; Sarais G; Mauri P; Merlini G
Biochim Biophys Acta; 2011 Mar; 1814(3):409-19. PubMed ID: 21215335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
